J

Josep Carreras Leukaemia Research Institute

200 employees

International research Institute that pursues to study and eradicate Leukaemia, Lymphoma and other Hemopathies.

Investor insights

Sectors invested in

Biomedicina2
Life Science2
Biotechnology2
Investigación2
Leucemia2
CARTs2
Hematología2
Biotecnología2
Medicina Personalizada2
Innovación2
Inmunoterapia2

Funding rounds participated in

$5.5M sweet spot round size

Most of their 2 investments are in rounds between $3.6M and $7.4M

Basic info

Industry

research services

Sectors

Chromatin
Genomics
Inmunotherapy
Lymphoma
Myelodysplastic syndromes
Leukaemia
Stem Cells
Malignant Haemopathies
Biomedicine
Inmunology
Haemathology
Epigenetics
Genetics
Multiple Myeloma
Cytomics

Date founded

2009

Investments made

O

OneChain Immunotherapeutics raised $7.4M on June 22, 2023

Investors: Clave Capital, Nara Capital, CDTI, Centre for the Development of Industrial Technology and Josep Carreras Leukaemia Research Institute

O

OneChain Immunotherapeutics raised $3.6M on July 27, 2020

Investors: Josep Carreras Leukaemia Research Institute

FAQ